SEC Form D · filed January 31, 2017
AIT Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Racheli Vizman · Rehovot, L3ExecYossef Av-Gay · Rehovot, L3DirectorRon Bentsur · Rehovot, L3DirectorAmir Avniel · Rehovot, L3Exec · DirectorAri Raved · Rehovot, L3DirectorJerome B. Zeldis · Rehovot, L3DirectorSteven A. Lisi · Rehovot, L3DirectorDavid Grossman · Rehovot, L3DirectorRandolph Klueger · WASHINGTON, D.C., Washington, D.C.Exec · DirectorJilla Berkman · Los Angeles, CAExecBrian Dunlay · Toledo, OHDirectorShallom Berkman · Los Angeles, CADirectorJohn Goodey · Toledo, OHDirectorGotcheva Lora · Toronto, Ontario, CanadaDirectorJeff M. Nunnenkamp · BEND, ORDirectorHenry Versendaal · Los Angeles, CADirectorDaniel W. Cummings · New York, NYExec · DirectorKimberly M. Crowley · West Conshohocken, PADirectorAdam Landau · West Conshohocken, PADirectorMichael Grey · San Diego, CAExecTjarko Hektor · NEW YORK, NYDirectorRodion E. Kritsberg · New York, NYDirectorGregory E. Kraut · New York, NYDirectorAvi Lewittes · CHICAGO, ILDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗